Removable anchored lung volume reduction devices and methods

Information

  • Patent Grant
  • 8926647
  • Patent Number
    8,926,647
  • Date Filed
    Friday, March 29, 2013
    11 years ago
  • Date Issued
    Tuesday, January 6, 2015
    9 years ago
Abstract
An intra-bronchial device may be placed and anchored in an air passageway of a patient to collapse a lung portion associated with the air passageway. The device includes an obstructing member that prevents air from being inhaled into the lung portion, and an anchor that anchors the obstruction device within the air passageway. The anchor may piercingly engage the air passageway wall. The anchor may be releasable from the air passageway for removal of the obstructing member. The anchor may be releasable by collapsing a portion of the obstructing member, or by drawing the obstructing member toward the larynx. The obstructing member may be a one-way valve.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention is generally directed to a removable anchored device, system, and method for treating Chronic Obstructive Pulmonary Disease (COPD). The present invention is more particularly directed to providing an anchored intra-bronchial obstruction that may be removable.


2. Description of the Related Art


COPD has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structural abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia, and smooth muscle hypertrophy in terminal bronchioles.


The incidence, prevalence, and health-related costs of COPD are on the rise. Mortality due to COPD is also on the rise. In 1991, COPD was the fourth leading cause of death in the United States and had increased 33% since 1979. COPD affects the patient's whole life. It has three main symptoms: cough; breathlessness; and wheeze. At first, breathlessness may be noticed when running for a bus, digging in the garden, or walking uphill. Later, it may be noticed when simply walking in the kitchen. Over time, it may occur with less and less effort until it is present all of the time. COPD is a progressive disease and currently has no cure. Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below.


The prevention of further respiratory damage entails the adoption of a healthy lifestyle. Smoking cessation is believed to be the single most important therapeutic intervention. However, regular exercise and weight control are also important. Patients whose symptoms restrict their daily activities or who otherwise have an impaired quality of life may require a pulmonary rehabilitation program including ventilatory muscle training and breathing retraining. Long-term oxygen therapy may also become necessary.


Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled betaagonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, ipratropium bromide may be indicated. Further, courses of steroids, such as corticosteroids, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pneumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.


About 40 years ago, it was first postulated that the tethering force that tends to keep the intrathoracic airways open was lost in emphysema and that by surgically removing the most affected parts of the lungs, the force could be partially restored. Although the surgery was deemed promising, the lung volume reduction surgery (LVRS) procedure was abandoned. LVRS was later revived. In the early 1990's, hundreds of patients underwent the procedure. However, the procedure has fallen out of favor when Medicare stopping reimbursing for LVRS. Unfortunately, data is relatively scarce and many factors conspire to make what data exists difficult to interpret. The procedure is currently under review in a controlled clinical trial. However, what data does exist tends to indicate that patients benefited from the procedure in terms of an increase in forced expiratory volume, a decrease in total lung capacity, and a significant improvement in lung function, dyspnea, and quality of life. Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory muscaulature, and improved right ventricular filling.


Lastly, lung transplantation is also an option. Today, COPD is the most common diagnosis for which lung transplantation is considered. Unfortunately, this consideration is given for only those with advanced COPD. Given the limited availability of donor organs, lung transplant is far from being available to all patients.


There is a need for additional non-surgical options for permanently treating COPD without surgery. A promising new therapy includes non-surgical apparatus and procedures for lung volume reduction by permanently obstructing the air passageway that communicates with the portion of the lung to be collapsed. The therapy includes placing an obstruction in the air passageway that prevents inhaled air from flowing into the portion of the lung to be collapsed. Lung volume reduction with concomitant improved pulmonary function may be obtained without the need for surgery. The effectiveness of obstructions may be enhanced if it is anchored in place. The effectiveness may also be enhanced if the obstruction is removable. However, no readily available apparatus and method exists for anchoring the obstruction, and for removal if required.


In view of the foregoing, there is a need in the art for a new and improved apparatus and method for permanently obstructing an air passageway that is anchored in place, and that may be removed if required. The present invention is directed to a device, system, and method that provide such an improved apparatus and method for treating COPD.


SUMMARY OF THE INVENTION

The present invention provides an anchored intrabronchial device for placement in an air passageway of a patient to collapse a lung portion associated with the air passageway. The device includes an obstructing member that prevents air from being inhaled into the lung portion to collapse the lung portion, and an anchor that anchors the obstruction device within the air passageway when the anchor is deployed. The anchor may engage the air passageway wall, and may pierce into the air passageway wall. The obstructing member and the anchor may be simultaneously deployable. The anchor may be releasable from the air passageway for removal of the obstructing member. A portion of the intra-bronchial device may be collapsible. The anchor may be releasable from the air passageway for removal of the obstructing member by collapsing a portion of the obstructing member, or by drawing the obstructing member proximally. The anchor may include a resilient material for imparting a force against the air passageway to deform the air passageway to more positively anchor the obstructing member. The anchor may comprise material having memory of an original shape, and resiliency to return the material to that shape. The obstructing member may comprise material having memory of an original shape, and resiliency to return the material to that shape. The obstructing member may be a one-way valve.


In another embodiment of the present invention, a method of reducing the size of a lung by collapsing a portion of the lung is provided. The method includes the step of providing an intra-bronchial device comprising an obstructing member which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and an anchor that anchors the obstructing member when the anchor is deployed. The method further includes the steps of placing the obstructing member in the air passageway, and deploying the anchor. The anchor may be releasable for removal of the obstructing member. The obstructing member may form a one-way valve. A portion of the obstructing member may be collapsible.


In a further embodiment of the present invention, a method of reducing the size of a lung by collapsing a portion of the lung with a removable device is provided. The method includes the step of providing an intra-bronchial device and an obstructing member that is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and an anchor that anchors the obstructing member when the anchor is deployed. The method includes the additional steps of placing the obstructing member in the air passageway, deploying an anchor, and removing the obstructing member. The anchor is releasable from the air passageway for removal of the intra-bronchial device, and the step of removing the obstructing member includes the further step of releasing the anchor. The obstructing member may form a one-way valve. At least a portion of the obstructing member may be collapsible, and the step of removing the obstructing member includes the further step of collapsing a portion of the obstructing member.


In yet another embodiment of the present invention, an air passageway-obstructing device is provided. The obstructing device includes obstructing means for obstructing air flow within the air passageway, and anchoring means to anchor the air passageway obstructing device within the air passageway.


In yet a further embodiment of the present invention, an air passageway-obstructing device is provided that includes obstructing means for obstructing air flow within the air passageway, and anchoring means to anchor the air passageway obstructing device within the air passageway, the anchoring means being releasable for removal of the obstructing means from the air passageway.


These and various other features as well as advantages which characterize the present invention will be apparent from a reading of the following detailed description and a review of the associated drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like referenced numerals identify like elements, and wherein:



FIG. 1 is a simplified sectional view of a thorax illustrating a healthy respiratory system;



FIG. 2 is a sectional view similar to FIG. 1, but illustrating a respiratory system suffering from COPD and the execution of a first step in treating the COPD condition by reducing the size of a lung portion in accordance with the present invention;



FIG. 3 is perspective view, partially in section, and to an enlarged scale, illustrating an intermediate step in the treatment;



FIG. 4 is a perspective view of a conduit that may 10 be utilized in practicing the present invention;



FIG. 5 is a perspective view of an intra-bronchial device, with anchors located proximally on peripheral portions of the support members, as the device would appear when fully deployed in an air passageway in accordance with the present invention;



FIG. 6 is a partial section view of the device of FIG. 5 showing additional details of the support structure;



FIG. 7 is a perspective view of the intra-bronchial device of FIG. 5 anchored in an air passageway;



FIG. 8 illustrates an intra-bronchial device, with anchors carried distally on the central support structure, fully deployed in an air passageway in accordance with an alternative embodiment of the invention;



FIG. 9 is a perspective view of an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;



FIG. 10 is a side view of an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;



FIG. 11 is an end view of an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;



FIG. 12 is a perspective view of an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;



FIG. 13 is a side view of an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;



FIG. 14 is an end view of an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;



FIG. 15 is a perspective view an intra-bronchial device similar to that of FIGS. 12-14 anchored in an air passageway;



FIG. 16 is a perspective view illustrating an alternative embodiment of a removable intra-bronchial device with proximal anchors carried on a peripheral portion of a plurality of support structure members in accord with the present invention;



FIG. 17 is a side view of the device of FIG. 16;



FIG. 18 is a perspective view of a device in its deployed state with anchors carried on an obstructing member, in accordance with an alternative embodiment of the invention;



FIG. 19 is a partial longitudinal sectional view of the device of FIG. 18 in a collapsed state and located into a lumen for placement in an air passageway;



FIG. 20 is a perspective view of the device of FIG. 18 in its deployed and anchored state in an air passageway, in accordance with the present invention;



FIG. 21 is a side view of an initial step in removing the device of FIG. 18 from an air passageway;



FIG. 22 is a side view of an intermediate step in removing the device of FIG. 18 from an air passageway;



FIG. 23 is a side view of another intermediate step in removing the device of FIG. 18 from an air passageway;



FIG. 24 is a side view illustrating the collapse of the device of FIG. 18 during its removal from an air passageway;



FIG. 25 is a perspective view of a device in its deployed state with anchors carried on the obstructing member, in accordance with an alternative embodiment of the present invention;



FIG. 26 illustrates the placement and securing of the obstructing member of the device of FIG. 25 to a support member; and



FIG. 27 is a perspective view of the intra-bronchial device of FIG. 25 fully deployed and anchored in an air passageway, in accordance with the present invention.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

In the following detailed description of exemplary embodiments of the invention, reference is made to the accompanying drawings that form a part hereof. The detailed description and the drawings illustrate how specific exemplary embodiments by which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention. It is understood that other embodiments may be utilized, and other changes may be made, without departing from the spirit or scope of the present invention. The following detailed description is therefore not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims.


Throughout the specification and claims, the following terms take the meanings explicitly associated herein unless the context clearly dictates otherwise. The meaning of “a”, “an”, and “the” include plural references. The meaning of “in” includes “in” and “on.” Referring to the drawings, like numbers indicate like parts throughout the views. Additionally, a reference to the singular includes a reference to the plural unless otherwise stated or inconsistent with the disclosure herein.


Additionally, throughout the specification, claims, and drawings, the term “proximal” means nearest the trachea, and “distal” means nearest the bronchioles.


Briefly stated, an aspect of the invention provides an anchored intra-bronchial device for placement in an air passageway of a patient to collapse a lung portion associated with the air passageway. A further aspect of the invention provides removability of the intra-bronchial device, either by releasing the anchors for removal of the entire device or by separating the obstructing member and removing it.



FIG. 1 is a sectional view of a healthy respiratory system. The respiratory system 20 resides within the thorax 22 that occupies a space defined by the chest wall 24 and the diaphragm 26.


The respiratory system 20 includes the trachea 28, the left mainstem bronchus 30, the right mainstem bronchus 32, the bronchial branches 34, 36, 38, 40, and 42 and sub-branches 44, 46, 48, and 50. The respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56, 58, and 60. Each bronchial branch and sub-branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof. As used herein, the term “air passageway” is meant to denote either a bronchi or bronchiole, and typically means a bronchial branch or sub-branch which communicates with a corresponding individual lung lobe or lung lobe portion to provide inhaled air thereto or conduct exhaled air therefrom.


Characteristic of a healthy respiratory system is the arched or inwardly arcuate diaphragm 26. As the individual inhales, the diaphragm 26 straightens to increase the volume of the thorax 22. This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.


In contrast to the healthy respiratory system of FIG. 1, FIG. 2 illustrates a respiratory system suffering from COPD. Here it may be seen that the lung lobes 52, 54, 56, 58, and 60 are enlarged and that the diaphragm 26 is not arched but substantially straight. Hence, this individual is incapable of breathing normally by moving diaphragm 28. Instead, in order to create the negative pressure in thorax 22 required for breathing, this individual must move the chest wall outwardly to increase the volume of the thorax. This results in inefficient breathing causing these individuals to breathe rapidly with shallow breaths.


It has been found that the apex portions 62 and 66 of the upper lung lobes 52 and 56, respectively, are most affected by COPD. Hence, bronchial sub-branch obstructing devices are generally employed for treating the apex 66 of the right, upper lung lobe 56. However, as will be appreciated by those skilled in the art, the present invention may be applied to any lung portion without departing from the present invention. As will be further appreciated by those skilled the in art, the present invention may be used with any type of obstructing member to provide an anchored obstructing device, which may be removed. The inventions disclosed and claimed in U.S. Pat. Nos. 6,258,100 and 6,293,951, both of which are incorporated herein by reference, provide an improved therapy for treating COPD by obstructing an air passageway using an intra-bronchial valve or plug. The present invention may be used with the apparatus, system, and methods of these patents as will be briefly described in conjunction with the disclosure of the preferred embodiments of the present invention.


The insertion of an obstructing member treats COPD by deriving the benefits of lung volume reduction surgery without the need of performing the surgery. The treatment contemplates permanent collapse of a lung portion. This leaves extra volume within the thorax for the diaphragm to assume its arched state for acting upon the remaining healthier lung tissue. As previously mentioned, this should result in improved pulmonary function due to enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricle filling. The present invention supports the use of intra-bronchial plugs to treat COPD by anchoring the obstruction device in the air passageway. The present invention further supports the use of intra-bronchial plugs by providing for their removal if necessary. Use of anchors can allow the obstructing member to be relatively loosely fitted against the air passageway wall, which may provide increased mucociliary transport of mucus and debris out of the collapsed lung portion.



FIG. 2 also illustrates a step in COPD treatment using an obstructing member. Treatment is initiated by feeding a conduit or catheter 70 down the trachea 28, into the right mainstem bronchus 32, into the bronchial branch 42 and into and terminating within the sub-branch 50. The sub-branch 50 is the air passageway that communicates with the lung portion 66 to be treated, and is also referred to herein as air passageway 50. The catheter 70 is preferably formed of flexible material such as polyethylene. Also, the catheter 70 is preferably preformed with a bend 72 to assist the feeding of the catheter from the right mainstem bronchus 32 into the bronchial branch 42.



FIG. 3 illustrates a further step in a method for placing an obstructing member 90 in a bronchial sub-branch using a catheter. The invention disclosed herein is not limited to use with the particular method illustrated herein. Catheter 70 includes an optional inflatable sealing member 74 for use with a vacuum to collapse lung portion 66 prior to insertion of obstructing member 90. The obstructing member 90 may be formed of resilient or collapsible material to enable the obstructing member 90 to be fed through the catheter 70 in a collapsed state. The obstructing member 90 and its anchors (not shown) are collapsed and fed into the catheter 70. The stylet 92 is used to push the obstructing member 90 to the end 77 of the catheter 70 for placing the obstructing member 90 within the air passageway 50 adjacent to the lung portion 66 to be permanently collapsed. Optional sealing member 74 is withdrawn after obstructing member 90 is inserted.


A function of the intra-bronchial device disclosed and claimed in this specification, including the detailed description and the claims, is described in terms of collapsing a lung portion associated with an air passageway. In some lungs, a portion of a lung may receive air from collateral air passageways. Obstructing one of the collateral air passageways may reduce the volume of the lung portion associated with the air passageway, but not completely collapse the lung portion as that term may be generally understood. As used herein, the meaning of “collapse” includes both a complete collapse of a lung portion and a partial collapse of a lung portion.


Once deployed, the obstructing member precludes inhaled air from entering the lung portion to be collapsed. In accordance with the present invention, it is preferable that the obstructing member takes the form of a one-way valve. In addition to precluding inhaled air from entering the lung portion, the member further allows air within the lung portion to be exhaled. This results in more rapid collapse of the lung portion. In addition, anchoring obstructing members that preclude both inhaled and exhaled airflow are contemplated as within the scope of the invention.



FIG. 4 illustrates the obstructing device in place within air passageway 50. Obstructing member 90 has expanded upon placement in the air passageway 50 to seal the air passageway 50. This causes the lung portion 66 to be maintained in a permanently collapsed state. The obstructing member 90 may be any shape suitable for accomplishing its purpose, and may be a solid material or a membrane.


More specifically, the obstructing member 90 has an outer dimension 91, and when expanded, enables a contact zone with the air passageway inner dimension 51. This seals the air passageway upon placement of the obstructing member 90 in the air passageway 50 for maintaining the lung portion 66 in the collapsed state.


Alternatively, the lung portion 66 may be collapsed using vacuum prior to placement of obstructing member 90, or sealing the air passageway 50 with obstructing member 90 may collapse it. Over time, the air within the lung portion 66 will be absorbed by the body and result in the collapse of lung portion 66. Alternatively, obstructing member 90 may include the function of a one-way valve that allows air to escape from lung portion 66. Lung portion 66 will then collapse, and the valve will prevent air from being inhaled.



FIG. 5 is a perspective view of an intra-bronchial device, with anchors located proximally on peripheral portions of the support members, as the device would appear when fully deployed in an air passageway in accordance with the present invention. Intra-bronchial device 100 includes a support structure 101, a central support structure 109; support members 102, 104, 106, and 108; anchors 112, 114, 116, and 118; anchor ends 122, 124, 126, and 128; and an obstructing member 110.


The support structure 101 of intra-bronchial device includes central support structure 109, and support members 102, 104, 106, and 108. The support members 102, 104, 106, and 108, carry anchors 112, 114, 116, and 118; and anchor ends 122, 124, 126, and 128, respectively. Central support structure 109 is a tubular member, preferably hypodermic needle tubing. Support members 102, 104, 106, and 108, are coupled mechanically to central support structure 109, such as by crimping, or by other methods such as adhesive or welding. Support members 102, 104, 106, and 108 are generally similar to each other. The support members are preferably formed of stainless steel, Nitinol, or other suitable material having a memory of its original shape, and resiliency to return the material to that shape.


Anchors 112, 114, 116, and 118 are extensions of support members 102, 104, 106, and 108. The anchors are formed by bending the support members to an angle that will result in a deployed anchor engaging the air passageway wall by piercing it approximately perpendicularly. In this preferred embodiment, the bend angle is approximately a right angle. Anchor ends 122, 124, 126, and 128 may be shaped to promote piercing the air passageway wall.


Obstructing member 110 is carried on the support structure 101, and includes a flexible membrane open in the proximal direction and which may be formed of silicone or polyurethane, for example. The obstructing member 110 is secured to the central support structure 109, and may be additionally secured to the support members at its larger diameter 91. It may be secured by adhesive, or other manner known in the art. Obstructing member 110 may be loosely carried on support members 102, 104, 106, and 108, such that it expands on inhalation to form a seal against a wall of the air passageway, and contracts on exhalation to allow air and mucociliary transport from the collapsed lung. This provides a one-way valve function.



FIG. 6 is a partial section view of the device of FIG. 5 showing additional detail of the support structure. The linear cross-section view of FIG. 6 exposes the arrangement of support members 106 and 108 in their deployed configuration.


The details of support members 102 and 104 are omitted from FIG. 6 for clarity, but are the same as support members 106 and 108. The distal end of obstructing member 110 is carried on central support structure 109. Support members 106 and 108 are shown emanating from central support structure 109, and arranged to loosely support to obstructing member 110 at its larger diameter 91. This allows obstructing member 110 to expand on inhalation and seal at the contact zone 129, and to partially contract on exhalation to allow exhalation of air and mucociliary transport.


In an alternative embodiment, support members 106 and 108 do not actively support obstructing member 110, and the expansion and contraction of obstructing member 110 is governed by its elasticity.



FIG. 7 is a perspective view of the intra-bronchial device of FIG. 5 anchored in an air passageway. Intra-bronchial device 100 is illustrated with anchors 112 and 116 piercing into the air passageway wall 130 of air passageway 50. This anchors the intra-bronchial device 100 in place.


Intra-bronchial device 100 is collapsible for insertion into an internal lumen of a catheter. At least the support members 102, 104, 106, and 108, and the obstructing member 110, may be collapsed. Intra-bronchial device 100 is inserted into the catheter lumen, which is typically already placed in the air passageway 50 as generally illustrated in FIG. 3. Using the stylet, intra-bronchial device 100 is advanced down the catheter lumen into the air passageway 50 to where the device is to be deployed. Once the point of deployment is reached, intra-bronchial device 100 is expelled from the catheter and assumes its deployed shape as illustrated in FIG. 5. Upon deployment, obstructing member 110 expands to form a contact zone 129 with the wall 130 of the air passageway 50 to prevent air from being inhaled into the lung portion to collapse the lung portion. Simultaneously upon deployment, the memory and resiliency of the support members 102, 104, 106, and 108 impart a force on the anchor ends 122, 124, 126, and 128, and urge the anchors 112, 114, 116, and 118 to engage air passageway wall 130 by piercing. The anchors pierce into and become embedded in the wall 130 of the air passageway 50, preferably without projecting through the wall 130. Stops may be incorporated into the anchors to limit piercing of the wall 130.


For example, the bend between the support member and the anchor may form a stop.


The preclusion of air from being inhaled into the lung portion may be terminated by eliminating the obstructing effect of intra-bronchial device 100. The preclusion of air by the embodiment illustrated in FIGS. 5-7 may be eliminated by releasing anchors 112, 114, 116, and 118 from the air passageway wall 130. The anchors may be released by inserting a catheter into air passageway 50 in proximity to intra-bronchial device 100. A retractor device, such as biopsy forceps, capable of gripping a portion of intra-bronchial device 100 is inserted in the catheter. The forceps are used to engage a portion of the support structure 101 of intra-bronchial device 100, and draw it toward the catheter. The drawing action releases anchors 112, 114, 116, and 118 from air passageway wall 130. The intrabronchial device 110 is then drawn into the catheter with the forceps, causing the support structure 101 and obstructing member 110 to collapse. The collapsed device 100 now fully enters the catheter lumen for removal from the patient. Alternatively, the obstructing effect may be eliminated by grabbing the obstructing member 110, releasing it from the support structure 101, and removing obstructing member 110 from the patient.



FIG. 8 illustrates an intra-bronchial device, with anchors carried distally on the central support structure, fully deployed in an air passageway in accordance with an alternative embodiment of the invention. The anchors 112, 114, 116, and 118 of intra-bronchial device 140 are carried on portions of support members 102, 104, 106, and 108 distal of the central support structure 109. The support members are gathered together and carried by the central support structure 109. Other than the anchors 112, 114, 116, and 118 being formed and carried on distal portions of support members 102, 104, 106, and 108, intra-bronchial device 140 is substantially similar in construction, operation, and removal as the intra-bronchial device 100 of FIG. 5.


When intra-bronchial device 140 is compressed for insertion into the catheter lumen for placement in the air passageway, the anchors, 112, 114, 116, and 118 are collapsed into a first configuration. In the first configuration, the anchor ends 122, 124, 126, and 128 are moved toward obstructing member 110, and anchors 112, 114, 116, and 118 thereby folded toward obstructing member 110. When intra-bronchial device 100 is deployed from the catheter lumen, the memory and resiliency of the support members 102, 104, 106, and 108 impart a force that moves the anchors 112, 114, 116, and 118 into a second configuration to engage air passageway wall 130. This is the deployed configuration illustrated in FIG. 8. For removal, drawing intra-bronchial device 140 toward the catheter causes the anchor ends 122, 124, 126, and 128 to move away from obstructing member 110 to a third configuration. Anchors 112, 114, 116, and 118 are thereby folded away from obstructing member 110 and are released from engagement with air passageway wall 130 for removal of the intra-bronchial device 140. In an alternative embodiment, the anchors 112, 114, 116, and 118 may be formed on additional support members carried by central support structure 109, instead of being formed from distal portions of support members 102, 104, 106, and 108.



FIGS. 9-11 illustrate an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention.



FIG. 9 is a perspective view, FIG. 10 is a side view, and FIG. 11 is an end view of the device. Intra-bronchial device 150 is generally similar in construction, operation, placement, and removal to the intra-bronchial device 100 of FIG. 5. Its structure has six support members and three anchors, with anchor stops. Anchors 112, 114, and 116 include stops 152, 154, and 156, respectively. Intra-bronchial device 150 also includes an anchor base 160, an anchor base aperture 165, anchor base angle 163, and additional support members 103 and 105.


Central support structure 109 extends both proximal and distal of obstructing member 110, and carries anchor base 161 proximal of obstructing member 110, carries anchors 112, 114, and 116, and includes anchor base aperture 165. The linear plane of anchors 112, 114, and 116 intersect anchor base 161 at anchor base angle 163. Anchor base angle 163 is selected to optimize anchor deployment force and anchor release. Stops 152, 154, and 156 include a flat area to limit the piercing of the air passageway wall by anchor ends 122, 124, and 126. In alternative embodiments, the stops can be any configuration or shape known to those skilled in the art to limit the piercing.


In operation, when intra-bronchial device 150 is compressed for insertion into the catheter lumen for placement in the air passageway, anchors 112, 114, and 116 are collapsed into a first configuration. In the first configuration, the anchor ends 122, 124, and 126 are moved toward obstructing member 110, thereby decreasing anchor base angle 163 and folding anchors 112, 114, and 116 toward obstructing member 110. The anchor ends and the anchors may be moved by sliding a catheter or hollow member over anchor base 161 and toward obstructing member 110. When intra-bronchial device 150 is deployed from the catheter lumen, the memory and resiliency of the anchors 112, 114, and 116, anchor angle 163, and anchor base 161 impart a force that moves the anchor members into a second configuration, which is the deployed configuration, to engage air passageway wall 130. The second or deployed configuration is illustrated in FIGS. 9-11. Stops 152, 154, and 156 limit the piercing of the air passageway wall by anchor ends 122, 124, and 126.


For removal, a retractor device is deployed from a catheter to engage anchor base 161 and restrain intra-bronchial device 150. The retractor device may be a biopsy forceps to engage anchor base 161, or a hooked device to engage anchor base aperture 165. A catheter is then moved distally over anchor base 161, and in contact with anchors 112, 114, and 116. The catheter is further moved against anchors 112, 114, and 116, while intra-bronchial device 150 is restrained at anchor base 161. This releases the anchors 112, 114, and 116 from the air passageway wall. This collapses the anchors into to the first configuration for removal. Intra-bronchial device 150 is then further drawn into the catheter by pulling on the retractor device used to engage anchor base 161. This collapses support structure 101 and obstructing member 110 so that they may be fully drawn into the catheter. Once drawn into the catheter, intra-bronchial device 160 may be removed from the air passageway and the patient.



FIGS. 12-14 illustrate an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention.



FIG. 12 is a perspective view, FIG. 13 is a side view, and FIG. 14 is an end view. Intra-bronchial device 160 is generally similar in construction, placement, and operation to the intra-bronchial device 150 of FIGS. 9-11. Intra-bronchial device 160 is removed in the manner described in conjunction with FIG. 7. However, Intra-bronchial device 160 differs from intra-bronchial device 150 in that the structure includes four distal anchors with anchor ends 122, 124, 126, and 128 shaped into pads that deform and frictionally engage the air passageway wall to more positively anchor intra-bronchial device 160 without piercing. The structure also includes an obstructing member support base 170.


Central support structure 109 extends distal of obstructing member 110, and carries anchor base 161 distal of obstructing member 110. Anchor base 161 carries anchors 112, 114, 116, and 118. The linear plane of anchors 112, 114, 116, and 118 intersects anchor base 161 at anchor angle 163. Anchor angle 163 is selected to optimize anchor deployment force and anchor release. The anchors 112, 114, 116, and 118, and anchor base 161 may be constructed by laser cutting a single piece of hypodermic tubing lengthwise to form the anchors 112, 114, 116, and 118, and then bending the anchors to form anchor angle 163. Anchor base 161 is secured to central support structure 109. Support members 102, 103, 104, 105, 106, and 108, and the obstructing member support member base 170 may be constructed in a like manner. Obstructing member 110 is secured to the obstructing member support base 170, and alternatively to support members 102, 103, 104, 105, 106, and 108. The assembly of obstructing member 110 and support base 170 is secured to central support structure 109. Central support structure 109 may extend proximal of support member base 170 to provide a surface for gripping the intra-bronchial device 160 for removal, and may include an aperture to be engaged by a hooked device.



FIG. 15 is a perspective view an intra-bronchial device similar to that of FIGS. 12-14 anchored in an air passageway. It illustrates pad-shaped anchor ends 122-128 of intra-bronchial device 180 deforming and frictionally engaging air passageway wall 130.



FIGS. 16 and 17 illustrate a removable intra-bronchial device with proximal anchors carried on a peripheral portion of a plurality of support structure members in accord with the present invention. FIG. 16 is a perspective view, as the device would appear when fully deployed in an air passageway. FIG. 17 is a side view of FIG. 16. In a preferred embodiment, the support structure 101 of intra-bronchial device 190 includes six support members, with two opposing pairs of support members carrying anchors and each member of a pair being joined together by a retracting member. Intra-bronchial device 190 includes a support structure 101 having a central support structure 109 and support members 102, 103, 104, 105, 106, and 108; four anchors 113, 114, 116, and 118 having anchor ends 123, 124, 126, and 128, respectively; two “U” shaped retracting members 192 and 194 having an apex 193 and 195, respectively; and obstructing member 110. As shown in FIG. 17, the support members extend in a curvilinear manner from the attachment at the central support structure 109 such that an umbrella or substantially parabolic shape is defined. In addition, as also shown in FIG. 17, the free ends of the support members 102, 103, 104, 105, 106, 108 are bent radially inwards. In other words, the illustrated support members 102, 104, 105, 106, 108 comprise tips at their free ends that are angled radially inwards.


Intra-bronchial device 190 is generally similar in construction, operation, placement, and removal to the intra-bronchial device 150 of FIG. 9. Support structure 101 is a tubular member, preferably hypodermic needle tubing, or stainless steel, Nitinol, or other suitable material having a memory of its original shape and resiliency to return the material to that shape. Support members 102, 103, 104, 105, 106, and 108, and central support structure 109 may be formed by laser cutting a single piece of hypodermic needle tubing lengthwise, and bending the support members to a required shape. Support members 102, 103, 104, 105, 106, and 108 are generally similar to each other. Anchors 113, 114, 116, and 118 are disposed on support members 103, 104, 106, and 108, respectively, in any manner available in the art. Anchors 113-118 are disposed on support members 103, 104, 106, and 108 to be located proximally of obstructing member 110, and to engage an air passageway wall when intra-bronchial device 190 is deployed.


“U” shaped retracting member 192 is coupled to support members 103 and 104, and “U” shaped retracting member 194 is coupled to support members 106 and 108. “U” shaped retracting members 192 and 194 may be constructed of any material suitable for use within a patient, and may or may not be resilient as required by the particular embodiment. When intra-bronchial device 190 is fully deployed in an air passageway, the “U” shaped retracting members 192 and 194 are arranged opposite each other, and they partially overlap, with the apex of one lying within a space bounded by the “U” shape of the other member. In the deployed configuration, increasing the distance between apex 193 and apex 195 moves support member pairs 103-104 and 106-108 centrally.


In operation, when intra-bronchial device 190 is compressed for insertion into a catheter lumen and placement in an air passageway, support members 102, 103, 104, 105, 106, and 108 are collapsed centrally into a first configuration. This causes the anchor ends 123-124, and 126-128 to move centrally.


When intra-bronchial device 190 is deployed from the catheter lumen, the memory and resiliency of the support member pairs 103, 104 and 106, 108 impart a force that moves the anchors 113 and 114, and 116 and 118, and their anchor ends 123 and 124, and 126 and 128 into a second configuration, which is the deployed configuration to engage air passageway wall. In addition, deployment of intra-bronchial device 190 may include a step of forcibly decreasing the distance between apexes 193 and 195 to forcibly move the anchors 113 and 114, and 116 and 118 into engagement with the wall of the air passageway. While the anchors 113 and 114, and 116 and 118 of this embodiment do not include stops, the expansive or peripheral movement of the anchors will be limited by obstructing member 90. This may limit the piercing of the air passageway wall by anchors 113 and 114, and 116 and 118.


In an alternative embodiment, support member pairs 103, 104 and 106, 108 may be compressed for insertion into a catheter lumen by a device that increases the distance between apex 193 and apex 195. Such a device could be a tool with spreading jaws, or a tapered member inserted between the apexes. The device could be left in engagement after insertion into the catheter, and then withdrawn to allow support member pairs 103-104 and 106-108 to move apart and engage their anchors into the wall of the air passageway.


For removal, a retractor device is deployed from a catheter lumen to engage apex 193 and 195, and restrain intra-bronchial device 190. The retractor device may be any device that fits into the space defined by apexes 193 and 195 when the intra-bronchial device 190 is in its fully deployed configuration. The retractor device is used to increase the distance between apexes 193 and 195 until anchors 113-114 and 116-118, and anchor ends 123-124 and 126-128 are released from the air passageway wall. This collapses the anchors into to the first configuration for removal. Intra-bronchial device 190 is then further collapsed, and drawn into the catheter by pulling on the retractor device. This additionally collapses support structure 101 and obstructing member 110 into the first position so that they may be fully drawn into the catheter. Once drawn into the catheter, intra-bronchial device 190 may be removed from the air passageway and the patient.



FIG. 18 is a perspective view of an intra-bronchial device 200 with anchors carried on an obstructing member as the device would appear when fully deployed in an air passageway, in accordance with an alternative embodiment of the invention. Intra-bronchial device 200 includes an obstructing member 90, anchors 111, 112, 113, 114, 115, 116, 117, and 118 (hereafter collectively referred to as anchors 111-118), and anchor ends 121, 122, 123, 124, 125, 126, 127, and 128 (hereafter collectively referred to as anchor ends 121-128).


Obstructing member 90 may be a single piece made from a collapsible, resilient material, such as silicone, polyurethane, rubber, or foam, and typically will be collapsible to at least one-half of its expanded size. In an alternative embodiment, obstructing member 90 may include multiple pieces, some being of collapsible material. In a further alternative embodiment, obstructing member 90 may include a membrane carried by a support structure such as described in conjunction with FIGS. 5-17.


Anchors 111-118 comprise material having memory of an original shape, and resiliency to return the material to that shape, and typically have a diameter small enough that penetration through an air passageway wall may not adversely effect a patient. Anchors 111-118 may be 0.003-inch diameter 316 stainless steel with a wire spring temper, Nitinol, or other resilient material. Anchor ends 121-128 may be shaped to promote or control piercing of the air passageway wall. In an alternative embodiment, the length of the anchors 111-118 may be limited to allow the anchors 111-118 to penetrate into but not through the air passageway wall. In the preferred embodiment illustrated in FIG. 18, the anchors include four pieces of material pushed through obstructing member 90. The four pieces would lie in approximately the same cross-sectional plane, and cross each other at approximately the centerline of obstructing member 90, with approximately equal portions of the anchor material projecting from opposite sides of the obstructing member 90. In this embodiment, for example, anchors 112 and 116 would be opposite portions of a single piece of material. Anchors 111-118 may be secured to control their position. For example, a centerline opening may be made in obstructing member 90 exposing the several pieces of anchoring material. The several pieces of material could them be joined together, or to obstructing member 90, at a location within the centerline opening by an adhesive, crimping, welding, or other method of mechanically joining materials known to those in the art.


In an alternative embodiment, the anchors may be formed by individual pieces of material. The individual pieces of material may be coupled to obstructing member 90 either at its periphery, or within its periphery.



FIG. 19 is a partial longitudinal sectional view of the intra-bronchial device of FIG. 18 collapsed and located into a delivery catheter lumen for placement in an air passageway to collapse a lung portion associated with the air passageway, in accordance with the present invention. Intra-bronchial device 200 is generally placed in an air passageway as described in FIGS. 2 and 3.


More specifically, intra-bronchial device 200 is collapsed and placed into delivery catheter lumen 70. Obstructing member 90 is collapsed into approximately a cylindrical shape. Anchors 111-118 are collapsed to a position in proximity to or against the outer periphery of collapsed obstructing member 90. Intra-bronchial device 200 is inserted into catheter lumen 70, the distal end of which is typically already placed in the air passageway 50 as generally illustrated in FIG. 3. Using stylet 92, intra-bronchial device 200 is advanced through the catheter lumen 70 into the air passageway to where it is to be deployed. Once the point of deployment is reached, intra-bronchial device 200 is expelled from catheter lumen 70, and assumes a deployed shape as illustrated in FIG. 18.



FIG. 20 is a perspective view of the intra-bronchial device of FIG. 18 in its fully deployed and anchored state in an air passageway, in accordance with the present invention. Intra-bronchial device 200 is illustrated after having been expelled from the catheter lumen in substantially the manner described in conjunction with FIG. 3, and having deployed anchors 112 and 116 by piercing into and through air passageway wall 130 of air passageway 50. The piercing engages the air passageway wall and anchors intra-bronchial device 200 within the air passageway 50.


The resiliency of obstructing member 90 imparts a force to expand the obstructing member 90 from the collapsed state to a deployed state. In its deployed state, obstructing member 90 forms a contact zone 129 with the wall 130 of air passageway 50 preventing air from being inhaled into the lung portion. The resiliency of the anchor members 111-118 moves them from their collapsed state illustrated in FIG. 19 to their deployed state. The resiliency of obstructing member 90 may assist anchor members 111-118 in deployment. In the alternative embodiment where the length of anchors 111-118 is limited to allow the anchors 111-118 to penetrate into but not through the air passageway wall, the anchors penetrate the air passageway wall 150 in the manner illustrated in FIG. 7.



FIGS. 21-24 are side views showing an embodiment of the present invention for removing the intra-bronchial device 200 from air passageway 50. The preclusion of air from being inhaled into the lung portion may be terminated by eliminating the obstructing effect of intra-bronchial device 200. The preclusion of air by the embodiment illustrated in FIG. 18 may be eliminated by releasing anchors 111-118 from the air passageway wall 130.


A bronchoscope 74 is placed in proximity to intrabronchial device 200 in the air passageway 50. A catheter 70 having an internal lumen 71 is fed into the bronchoscope 74 and advanced to the proximal end of the intra-bronchial device 200. A retractor device, such as biopsy forceps 76, capable of gripping a portion of intra-bronchial device 200, is inserted in the catheter 70 of the bronchoscope 74 and advanced to the intra-bronchial device 200. The jaws of the forceps 76 are used to engage a portion of the obstructing member 90. The engagement may collapse a portion of obstructing member 90. The engagement with the obstructing member 90 is maintained and obstructing member 90 is drawn toward the catheter lumen 71 by the forceps 76. The drawing action releases anchors 111-118 from air passageway wall 130. The intra-bronchial device 200 is then drawn into the catheter lumen 71 with the forceps 76. The collapsed device 200 now fully enters the catheter lumen 71 for removal from the patient.



FIG. 25 is a perspective view of an intra-bronchial device with anchors projecting from a periphery of an obstructing member as the device would appear when fully deployed, in accordance with an alternative embodiment of the present invention. The intra-bronchial device 210 includes support members 102, 104, 106, and 108; an obstructing member 110; “s” shaped bends 212, 214, 216, and 218; and anchors 112, 114, 116, and 118.


The support members 102, 104, 106, and 108 form a support structure carrying obstructing member 110, and include anchors 112, 114, 116, and 118; and anchor ends 122, 124, 126, and 128, respectively. The support members 102, 104, 106, and 108 may be tubular members, and are preferably hypodermic needle tubing. Support members 102, 104, 106, and 108 form a support structure by being joined together at a location toward the distal portion of intra-bronchial device 210. They may be joined by a mechanical method, such as by crimping, or by other methods such as adhesive or welding. In an alternative embodiment, two support members may be formed from a single piece of material by bending it in the middle. Support members 102, 104, 106, and 108 are generally similar to each other. The support members are preferably formed of stainless steel, Nitinol, or other suitable material having a memory of its original shape, and resiliency to return the material to that shape.


Anchors 112, 114, 116, and 118 are extensions of support members 102, 104, 106, and 108. The anchors are formed by forming “s” shaped bends 212, 214, 216, and 218 in proximal portions of the support members. Anchor ends 122, 124, 126, and 128 may be shaped to promote piercing the air passageway wall.


The obstructing member 110 is carried on the support structure formed by support members 102, 104, 106, and 108. Obstructing member 110 includes a flexible membrane open in the proximal direction and which may be formed of silicone or polyurethane, for example. The obstructing member 110 includes openings 222, 224, 226, and 228 sized to sealingly admit the “s” shaped bends 212, 214, 216, and 218 of support members 102, 104, 106, and 108, respectively. FIG. 26 illustrates the placement and securing of the obstructing member 110 to support member 102 at “s” bend 212.


Obstructing member 110 is fitted over the anchor end 122 and anchor 112 at opening 222. Obstructing member 110 engages the peripheral apex of the “s” shaped bend 212, and thus secures it. The obstructing member 110 is placed and secured to the other “s” bends 214, 216, and 218 in a similar manner.


Obstructing member 110 may be loosely carried on support members 102, 104, 106, and 108 such that it expands on inhalation to form a seal against a wall of the air passageway, and contracts on exhalation to allow air and mucociliary transport from the collapsed lung. This provides a one-way valve function.



FIG. 27 is a perspective view of the intra-bronchial device of FIG. 25 fully deployed and anchored in an air passageway, in accordance with the present invention. Intracustom characterbronchial device 210 is illustrated after having been expelled from the catheter lumen in substantially the manner described in conjunction with FIG. 3, and having deployed anchors 112, 114, 116, and 118 by piercing into air passageway wall 130 of air passageway 50. The piercing engages the air passageway wall and anchors intra-bronchial device 210 within the air passageway 50.


Deploying obstructing member 210 is much like opening an umbrella. Upon deployment, the memory and resiliency of the support members 102, 104, 106, and 108, expand obstructing member 210. The expanded obstructing member 210 forms a contact zone 129 with the wall 130 of the air passageway 50 to prevent air from being inhaled into the lung portion to collapse the lung portion. Simultaneously upon deployment, the memory and resiliency of the support members 102, 104, 106, and 108 impart a force on the anchor ends 122, 124, 126, and 128, and urge the anchors 112, 114, 116, and 118 to engage air passageway wall 130 by piercing. The anchors pierce into and become embedded in the wall 130 of the air passageway 50, preferably without projecting through the wall 130. Stops may be incorporated into the anchors to limit piercing of the wall 130. For example, the “s” bends 212, 214, 216, and 218 may form a stop.


The preclusion of air from being inhaled into the lung portion may be terminated by eliminating the obstructing effect of intra-bronchial device 210. The preclusion of air by the embodiment illustrated in FIGS. 25-27 may be eliminated by releasing anchors 112, 114, 116, and 118 from the air passageway wall 130. The anchors are released and the intra-bronchial device 210 is removed from air passageway 50 in substantially the same manner described in conjunction with FIGS. 7, and 21-24. The forceps are used to engage a portion of intra-bronchial device 210, and maneuvered to release anchors 112, 114, 116, and 118 from the air passageway wall 130. Intra-bronchial device 210 is then drawn into the catheter for removal from the patient. Alternatively, the obstructing effect may be eliminated by engaging the obstructing member 210, releasing it from the support members 102, 104, 106, and 108, and drawing obstructing member 110 into the catheter for removal from the patent.


Although the present invention has been described in considerable detail with reference to certain preferred embodiments, other embodiments are possible. Therefore, the spirit or scope of the appended claims should not be limited to the description of the embodiments contained herein. It is intended that the invention resides in the claims hereinafter appended.

Claims
  • 1. A medical device for treating a lung, the medical device comprising: a support structure comprising: a central support structure having a proximal end and a distal end and an axial centerline; anda plurality of support members extending in a proximal direction from the central support structure away from the axial centerline of the central support structure, one or more of the plurality of support members having a bent portion on a proximal end of the support member, the bent portion pointing away from the axial centerline; andan obstructing member comprising a flexible membrane, the obstructing member having a proximal end and a distal end, the proximal end of the obstructing member having cross dimension greater than a cross dimension of the distal end of the obstructing member, at least a portion of the obstructing member overlaying and in contact with at least a portion of the support members; wherein the medical device functions as a one way valve to permit inspiratory flow of air through an airway while occluding expiratory flow in the airway; and wherein the proximal end of the central support structure is positioned proximal to the distal end of the obstructing member.
  • 2. The medical device of claim 1, wherein the bent portion includes an anchor end.
  • 3. The medical device of claim 1, wherein the bent portion is positioned on a periphery of the proximal end of the obstructing member.
  • 4. The medical device of claim 1, wherein the plurality of support members are constructed from a shape memory material.
  • 5. The medical device of claim 1, wherein the obstructing member forms a concave proximal face.
  • 6. The medical device of claim 1, wherein the medical device is configured to permit fluid to pass between the flexible membrane a wall of an airway in an inspiratory direction when the medical device is deployed in the airway.
  • 7. The medical device of claim 1, wherein at least a portion of one or more of the support members is positioned within the central support structure.
  • 8. An intra-bronchial device comprising: a tubular structure having a proximal end, a distal end, and an axial centerline;a plurality of strut arms extending from the proximal end of the tubular structure away from the axial centerline of the tubular structure, each of the plurality of strut arms having a proximal end and a distal end;a membrane in contact with an outer surface of at least a portion of the plurality of strut arms, the membrane having a proximal end and a distal end, the distal end of the membrane attached to the tubular structure, the proximal end of the membrane connected to at least one of the plurality of strut arms;at least one of the plurality of strut arms including an arcuate portion on a proximal end of the at least one strut arm, the arcuate portion including a tip shaped for anchoring the intra-bronchial device relative to an interior lumen wall of a lung airway, the membrane configured to at least partially occlude airflow through the lung airway in at least one direction; and wherein the proximal end of the tubular structure is positioned proximal to the distal end of the membrane.
  • 9. The intra-bronchial device of claim 8, wherein the intra-bronchial device functions as a one-way valve to permit inspiratory flow of air through a lung airway while occluding expiratory flow in the lung airway.
  • 10. The intra-bronchial device of claim 8, wherein the proximal end of the membrane is further from the axial centerline of the tubular structure than the distal end of the membrane when the intra-bronchial device is in a deployed configuration.
  • 11. The intra-bronchial device of claim 8, wherein the arcuate portion is positioned on a periphery of the proximal end of the membrane.
  • 12. The intra-bronchial device of claim 8, wherein the plurality of strut arms are constructed from a shape memory material.
  • 13. The intra-bronchial device of claim 8, wherein intra-bronchial device occludes fluid flow in the lung airway in an inspiratory direction when the intra-bronchial device is deployed in the lung airway.
  • 14. The intra-bronchial device of claim 8, wherein the intra-bronchial device is configured to permit fluid to pass between the membrane and a wall of the lung airway in an inspiratory direction when the intra-bronchial device is deployed in the lung airway.
  • 15. The intra-bronchial device of claim 8, wherein at least a portion of one or more of the struts is positioned within the tubular structure.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 13/415,616, titled REMOVABLE ANCHORED LUNG VOLUME REDUCTION DEVICES AND METHODS and filed Mar. 8, 2012, which is now pending. U.S. patent application Ser. No. 13/415,616 is a continuation of U.S. patent application Ser. No. 13/198,546, titled REMOVABLE ANCHORED LUNG VOLUME REDUCTION DEVICES AND METHODS and filed Aug. 4, 2011, now U.S. Pat. No. 8,177,805. U.S. patent application Ser. No. 13/198,546 is a continuation of U.S. patent application Ser. No. 11/880,090, titled REMOVABLE ANCHORED LUNG VOLUME REDUCTION DEVICES AND METHODS and filed Jul. 19, 2007, now U.S. Pat. No. 8,021,385. U.S. patent application Ser. No. 11/880,090 is a continuation of U.S. patent application Ser. No. 10/103,487, titled REMOVABLE ANCHORED LUNG VOLUME REDUCTION DEVICES AND METHODS and filed Mar. 20, 2002, now abandoned. The foregoing applications are hereby incorporated by reference herein in their entirety. Any and all priority claims identified in the Application Data Sheet, or any correction thereto, are hereby incorporated by reference under 37 CFR 1.57.

US Referenced Citations (509)
Number Name Date Kind
2115298 Brown Apr 1938 A
2728225 Skibitzke Dec 1955 A
2832078 Williams Apr 1958 A
2981254 Vanderbilt Apr 1961 A
3320972 High et al. May 1967 A
3370305 Goott et al. Feb 1968 A
3445916 Schulte May 1969 A
3472230 Forgarty Oct 1969 A
3540431 Modin-Uddin Nov 1970 A
3617060 Iezzi Nov 1971 A
3657744 Ersek Apr 1972 A
3671979 Moulopoulos Jun 1972 A
3683913 Kurtz et al. Aug 1972 A
3757783 Alley Sep 1973 A
3760808 Bleuer Sep 1973 A
3788327 Donowitz et al. Jan 1974 A
3874388 King et al. Apr 1975 A
3889657 Baumgarten Jun 1975 A
3962917 Terada Jun 1976 A
4014318 Dockum et al. Mar 1977 A
4040428 Clifford Aug 1977 A
4056854 Boretos et al. Nov 1977 A
4084268 Ionescu et al. Apr 1978 A
4086665 Poirlier May 1978 A
4205282 Gipprich May 1980 A
4212463 Repinski et al. Jul 1980 A
4218782 Rygg Aug 1980 A
4222126 Boretos et al. Sep 1980 A
4250873 Bonnet Feb 1981 A
4267839 Laufe et al. May 1981 A
4301810 Belman Nov 1981 A
4302854 Runge Dec 1981 A
4339831 Johnson Jul 1982 A
RE31040 Possis Sep 1982 E
4393879 Milgrom Jul 1983 A
4402445 Green Sep 1983 A
4403616 King Sep 1983 A
4456016 Nowacki et al. Jun 1984 A
4483200 Togawa et al. Nov 1984 A
4512338 Balko et al. Apr 1985 A
4533137 Sonne Aug 1985 A
4569674 Phillips et al. Feb 1986 A
4582058 Depel et al. Apr 1986 A
4583541 Barry Apr 1986 A
4592741 Vincent Jun 1986 A
4601465 Roy Jul 1986 A
4610256 Wallace Sep 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4654027 Dragan et al. Mar 1987 A
4654029 D'Antonio Mar 1987 A
4681110 Wiktor Jul 1987 A
4684363 Ari et al. Aug 1987 A
4685908 Kurtz Aug 1987 A
4710192 Liotta et al. Dec 1987 A
4727873 Mobin-Uddin Mar 1988 A
4732152 Wallsten et al. Mar 1988 A
4745925 Dietz May 1988 A
4759758 Gabbay Jul 1988 A
4795449 Schneider et al. Jan 1989 A
4799311 Matsutani Jan 1989 A
4808183 Panje Feb 1989 A
4819664 Nazari Apr 1989 A
4822354 Elosegui Apr 1989 A
4830003 Wolff et al. May 1989 A
4832680 Haber et al. May 1989 A
4846836 Reich Jul 1989 A
4850999 Planck Jul 1989 A
4852552 Chaux Aug 1989 A
4852568 Kensey Aug 1989 A
4870975 Cronk et al. Oct 1989 A
4877025 Hanson Oct 1989 A
4881939 Newman Nov 1989 A
4888015 Domino Dec 1989 A
4896668 Popoff et al. Jan 1990 A
4908028 Colon et al. Mar 1990 A
4920978 Colvin May 1990 A
4934999 Bader Jun 1990 A
4936823 Colvin et al. Jun 1990 A
4968294 Salama Nov 1990 A
4973047 Norell Nov 1990 A
4979505 Cox Dec 1990 A
4984581 Stice Jan 1991 A
4995872 Ferrara Feb 1991 A
5002772 Curatolo et al. Mar 1991 A
5019086 Neward May 1991 A
5033312 Stupecky Jul 1991 A
5038621 Stupecky Aug 1991 A
5059208 Coe et al. Oct 1991 A
5061274 Kensey Oct 1991 A
5078739 Martin Jan 1992 A
5092781 Casciotti et al. Mar 1992 A
5111823 Komberg et al. May 1992 A
5116360 Pinchuk et al. May 1992 A
5116564 Jansen et al. May 1992 A
5123919 Sauter et al. Jun 1992 A
5127412 Csometto et al. Jul 1992 A
5135488 Foote et al. Aug 1992 A
5135531 Shiber Aug 1992 A
5147369 Wagner Sep 1992 A
5151105 Kwan-Gett Sep 1992 A
5158548 Lau et al. Oct 1992 A
5161524 Evans Nov 1992 A
5171299 Heitzmann et al. Dec 1992 A
5186711 Epstein Feb 1993 A
5197485 Grooters Mar 1993 A
5197963 Parins Mar 1993 A
5197980 Gorshkov et al. Mar 1993 A
5207702 Pearl May 1993 A
5226429 Kuzmak Jul 1993 A
5255687 McKenna Oct 1993 A
5275169 Afromowitz et al. Jan 1994 A
5281229 Neward Jan 1994 A
5283063 Freeman Feb 1994 A
5300050 Everett, Jr. et al. Apr 1994 A
5304199 Myers Apr 1994 A
5306234 Johnson Apr 1994 A
5314473 Godin May 1994 A
5339805 Parker Aug 1994 A
5342298 Michaels Aug 1994 A
5350388 Epstein Sep 1994 A
5352240 Ross Oct 1994 A
5353470 Bartlett Oct 1994 A
5356412 Golds et al. Oct 1994 A
5358518 Camilli Oct 1994 A
5366475 Voss et al. Nov 1994 A
5366478 Brinkerhoff et al. Nov 1994 A
5370657 Irie Dec 1994 A
5382261 Palmaz Jan 1995 A
5383470 Kolby Jan 1995 A
5391205 Knight Feb 1995 A
5392775 Adkins, Jr. et al. Feb 1995 A
5398844 Zaslavsky Mar 1995 A
5409019 Wilk Apr 1995 A
5409444 Kensey et al. Apr 1995 A
5411507 Heckele May 1995 A
5411552 Andersen et al. May 1995 A
5413599 Imachi et al. May 1995 A
5415658 Kipela et al. May 1995 A
5415660 Campbell et al. May 1995 A
5417226 Juma May 1995 A
5421325 Cinberg et al. Jun 1995 A
5423830 Schneebaum et al. Jun 1995 A
5445626 Gigante Aug 1995 A
5453090 Martenez et al. Sep 1995 A
5456689 Kresch et al. Oct 1995 A
5459544 Emura Oct 1995 A
5484444 Braunschweiler et al. Jan 1996 A
5486154 Kelleher Jan 1996 A
5490860 Middle et al. Feb 1996 A
5499995 Teirstein Mar 1996 A
5500014 Quijano et al. Mar 1996 A
RE35225 Herweck et al. Apr 1996 E
5503638 Cooper Apr 1996 A
5507754 Green et al. Apr 1996 A
5507797 Suzuki Apr 1996 A
5509900 Kirkman Apr 1996 A
5514153 Bonutti et al. May 1996 A
5549626 Miller et al. Aug 1996 A
5549628 Cooper et al. Aug 1996 A
5562608 Sekins et al. Oct 1996 A
5562641 Flomenblit et al. Oct 1996 A
5562728 Lazarus et al. Oct 1996 A
5575293 Miller et al. Nov 1996 A
5593413 Alexander Jan 1997 A
5603698 Roberts et al. Feb 1997 A
5607469 Frey Mar 1997 A
5645565 Rudd et al. Jul 1997 A
5647857 Andersen et al. Jul 1997 A
5649953 Lefebvre Jul 1997 A
5660175 Dayal Aug 1997 A
5662622 Gore et al. Sep 1997 A
5662713 Andersen et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5676671 Inoue Oct 1997 A
5683451 Lenker et al. Nov 1997 A
5690644 Yurek et al. Nov 1997 A
5693089 Inoue Dec 1997 A
5697968 Rogers et al. Dec 1997 A
5702343 Alferness Dec 1997 A
5702409 Rayburn et al. Dec 1997 A
5725519 Penner et al. Mar 1998 A
5741271 Nakao et al. Apr 1998 A
5752522 Murphy May 1998 A
5752965 Francis et al. May 1998 A
5755770 Ravenscroft May 1998 A
5763979 Mukherjee et al. Jun 1998 A
5766134 Lisak et al. Jun 1998 A
5769892 Kingwell Jun 1998 A
5772583 Wright et al. Jun 1998 A
5779649 Herbert Jul 1998 A
5782896 Chen et al. Jul 1998 A
5797907 Clement Aug 1998 A
5797920 Kim Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5800339 Salama Sep 1998 A
5803078 Brauner Sep 1998 A
5810806 Ritchart et al. Sep 1998 A
5810809 Rydell Sep 1998 A
5810837 Hofmann et al. Sep 1998 A
5810855 Rayburn et al. Sep 1998 A
5817101 Fiedler Oct 1998 A
2479805 Sabaratnam Nov 1998 A
5830217 Ryan Nov 1998 A
5833694 Poncet Nov 1998 A
5840081 Andersen et al. Nov 1998 A
5851232 Lois Dec 1998 A
5855587 Hyon Jan 1999 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5865724 Palmer et al. Feb 1999 A
5876434 Flomenblit et al. Mar 1999 A
5876445 Andersen et al. Mar 1999 A
5895387 Guerrero et al. Apr 1999 A
5902312 Frater et al. May 1999 A
5911756 Debry Jun 1999 A
5925063 Khosravi Jul 1999 A
5944738 Amplatz et al. Aug 1999 A
5947997 Pavcnik et al. Sep 1999 A
5954636 Schwartz et al. Sep 1999 A
5954766 Zadno-Azizi et al. Sep 1999 A
5957949 Leonhardt et al. Sep 1999 A
5957978 Blom Sep 1999 A
5972009 Fortier et al. Oct 1999 A
5976158 Adams et al. Nov 1999 A
5976174 Ruiz Nov 1999 A
5980545 Pacala et al. Nov 1999 A
5984965 Knapp et al. Nov 1999 A
5989234 Valerio et al. Nov 1999 A
6003517 Sheffield et al. Dec 1999 A
6007575 Samuels Dec 1999 A
6009614 Morales Jan 2000 A
6010511 Murphy Jan 2000 A
6010525 Bonutti et al. Jan 2000 A
6020380 Killian Feb 2000 A
6024759 Nuss et al. Feb 2000 A
6027525 Suh et al. Feb 2000 A
6045560 McKean et al. Apr 2000 A
6051022 Cai et al. Apr 2000 A
6053877 Banik et al. Apr 2000 A
6062575 Mickel et al. May 2000 A
6068635 Gianotti May 2000 A
6068638 Makower May 2000 A
6077214 Schweich et al. Jun 2000 A
6077291 Das Jun 2000 A
6079413 Baran Jun 2000 A
6083141 Hougen Jul 2000 A
6083255 Laufer et al. Jul 2000 A
6086543 Anderson et al. Jul 2000 A
6090035 Campell et al. Jul 2000 A
6090041 Clark Jul 2000 A
6096027 Layne Aug 2000 A
6099551 Gabbay Aug 2000 A
6102885 Bass Aug 2000 A
6102926 Tartaglia et al. Aug 2000 A
6123663 Rebuffat Sep 2000 A
6132458 Staehle et al. Oct 2000 A
6135729 Aber Oct 2000 A
6135991 Muni et al. Oct 2000 A
6141855 Morales Nov 2000 A
6142957 Diamond et al. Nov 2000 A
6146357 Addis Nov 2000 A
6146384 Lee et al. Nov 2000 A
6146388 McDonald Nov 2000 A
6149664 Kurz Nov 2000 A
6162245 Jayaraman Dec 2000 A
6165179 Cathcart et al. Dec 2000 A
6168614 Andersen et al. Jan 2001 B1
6168617 Blaeser et al. Jan 2001 B1
6174307 Daniel et al. Jan 2001 B1
6174323 Biggs Jan 2001 B1
6183520 Pintauro et al. Feb 2001 B1
6193748 Thompson et al. Feb 2001 B1
6200333 Laufer Mar 2001 B1
6203551 Wu Mar 2001 B1
6206918 Campbell et al. Mar 2001 B1
6210338 Afremov et al. Apr 2001 B1
6213957 Milliman et al. Apr 2001 B1
6231587 Makower May 2001 B1
6231589 Wessman et al. May 2001 B1
6234996 Bagaoisan et al. May 2001 B1
6238334 Easterbrook, III et al. May 2001 B1
6240615 Kimes et al. Jun 2001 B1
6241654 Alferness Jun 2001 B1
6241678 Afremov et al. Jun 2001 B1
6241758 Cox Jun 2001 B1
6242472 Sekins et al. Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6258100 Alferness et al. Jul 2001 B1
6264700 Kilcoyne et al. Jul 2001 B1
6267775 Clerc et al. Jul 2001 B1
6270527 Campbell et al. Aug 2001 B1
6277083 Eggers et al. Aug 2001 B1
6280398 Ritchart et al. Aug 2001 B1
6287290 Perkins et al. Sep 2001 B1
6287334 Moll et al. Sep 2001 B1
6293951 Alferness et al. Sep 2001 B1
6296639 Truckai et al. Oct 2001 B1
6299604 Ragheb et al. Oct 2001 B1
6302893 Limon et al. Oct 2001 B1
6312407 Zadno-Azizi et al. Nov 2001 B1
6322522 Zimmon Nov 2001 B1
6325777 Zadno-Azizi et al. Dec 2001 B1
6325778 Zadno-Azizi et al. Dec 2001 B1
6327505 Medhkour et al. Dec 2001 B1
6327772 Zadno-Azizi et al. Dec 2001 B1
6328689 Gonzalez et al. Dec 2001 B1
6331183 Suon Dec 2001 B1
6338728 Valerio et al. Jan 2002 B1
6342062 Suon et al. Jan 2002 B1
6350278 Lenker et al. Feb 2002 B1
6355014 Zadno-Azizi et al. Mar 2002 B1
6398775 Perkins et al. Jun 2002 B1
6402754 Gonzalez Jun 2002 B1
6416554 Alferness et al. Jul 2002 B1
6425916 Garrison et al. Jul 2002 B1
6428561 Johansson-Ruden et al. Aug 2002 B1
6439233 Geertsema Aug 2002 B1
6440164 DiMatteo et al. Aug 2002 B1
6447530 Ostrovsky et al. Sep 2002 B1
6454727 Burbank et al. Sep 2002 B1
6454754 Frank Sep 2002 B1
6458076 Pruitt Oct 2002 B1
6458153 Bailey et al. Oct 2002 B1
6471718 Staehle et al. Oct 2002 B1
6471979 New et al. Oct 2002 B2
6485407 Alferness et al. Nov 2002 B2
6485436 Truckai et al. Nov 2002 B1
6488673 Laufer Dec 2002 B1
6491706 Alferness et al. Dec 2002 B1
6493589 Medhkour et al. Dec 2002 B1
6503272 Duerig et al. Jan 2003 B2
6506166 Hendler et al. Jan 2003 B1
6510846 O'Rourke Jan 2003 B1
6514290 Loomas Feb 2003 B1
6527761 Soltesz et al. Mar 2003 B1
6540767 Walak et al. Apr 2003 B1
6540782 Snyders Apr 2003 B1
6544192 Starr et al. Apr 2003 B2
6544291 Taylor Apr 2003 B2
6551255 Van Bladel et al. Apr 2003 B2
6551303 Van Tassel et al. Apr 2003 B1
6558429 Taylor May 2003 B2
6568387 Davenport et al. May 2003 B2
6569166 Gonzalez May 2003 B2
6585639 Kotmel et al. Jul 2003 B1
6589240 Hinchliffe Jul 2003 B2
6589256 Forber Jul 2003 B2
6592594 Rimbaugh et al. Jul 2003 B2
6599304 Selmon et al. Jul 2003 B1
6599311 Biggs et al. Jul 2003 B1
6600307 Turski Jul 2003 B2
6610043 Ingenito Aug 2003 B1
6620095 Taheri Sep 2003 B2
6629951 Laufer et al. Oct 2003 B2
6632239 Snyder et al. Oct 2003 B2
6632243 Zadno-Azizi et al. Oct 2003 B1
6634363 Danek et al. Oct 2003 B1
6638285 Gabbay Oct 2003 B2
6648897 Hamilton Nov 2003 B2
6669724 Park et al. Dec 2003 B2
6673070 Edwards et al. Jan 2004 B2
6679264 Deem et al. Jan 2004 B1
6682250 Banks Jan 2004 B2
6682520 Ingenito Jan 2004 B2
6694979 Deem et al. Feb 2004 B2
6709401 Perkins et al. Mar 2004 B2
6712812 Roschak et al. Mar 2004 B2
6716208 Humes Apr 2004 B2
6722360 Doshi Apr 2004 B2
6743259 Ginn Jun 2004 B2
6746686 Hughes et al. Jun 2004 B2
6749606 Keast et al. Jun 2004 B2
6749658 DeVore et al. Jun 2004 B1
6840952 Saker et al. Jan 2005 B2
6849049 Starr et al. Feb 2005 B2
6849084 Rabkin et al. Feb 2005 B2
6852108 Barry et al. Feb 2005 B2
6860847 Alferness et al. Mar 2005 B2
6886558 Tanaka May 2005 B2
6887256 Gilson May 2005 B2
6904909 Andreas et al. Jun 2005 B2
6911028 Shadduck Jun 2005 B2
6929637 Gonzalez et al. Aug 2005 B2
6941950 Wilson et al. Sep 2005 B2
6951571 Srivastava Oct 2005 B1
6955675 Jain Oct 2005 B2
6958059 Zadno-Azizi Oct 2005 B2
6958076 Acosta et al. Oct 2005 B2
6989027 Allen et al. Jan 2006 B2
6997951 Solem et al. Feb 2006 B2
7011094 Rapacki et al. Mar 2006 B2
7077851 Lutze et al. Jul 2006 B2
7086398 Tanaka Aug 2006 B2
7100616 Springmeyer Sep 2006 B2
7141046 Perkins et al. Nov 2006 B2
7169140 Kume Jan 2007 B1
7175644 Cooper et al. Feb 2007 B2
7207946 Sirokman Apr 2007 B2
7232414 Gonzalez Jun 2007 B2
7252086 Tanaka Aug 2007 B2
7273469 Chan et al. Sep 2007 B1
7278430 Kumar Oct 2007 B2
7344553 Opolski et al. Mar 2008 B2
7357795 Kaji et al. Apr 2008 B2
7412977 Fields et al. Aug 2008 B2
7422584 Loomas et al. Sep 2008 B2
7434578 Dillard et al. Oct 2008 B2
7476203 DeVore et al. Jan 2009 B2
7530995 Quijano et al. May 2009 B2
7533671 Gonzalez et al. May 2009 B2
7575692 Kimura Aug 2009 B2
7637934 Mangiardi et al. Dec 2009 B2
7662181 Deem et al. Feb 2010 B2
7691151 Kutsko Apr 2010 B2
7704268 Chanduszko Apr 2010 B2
7757692 Alferness et al. Jul 2010 B2
7771472 Hendricksen et al. Aug 2010 B2
7798974 Sirokman Sep 2010 B2
7842061 Dillard et al. Nov 2010 B2
7854228 Wilson et al. Dec 2010 B2
7862500 Khairkhahan et al. Jan 2011 B2
7875048 Dillard et al. Jan 2011 B2
7887585 Gonzalez et al. Feb 2011 B2
7896887 Rimbaugh et al. Mar 2011 B2
7913698 Barry et al. Mar 2011 B2
7942931 Gonzalez et al. May 2011 B2
8021385 Alferness Sep 2011 B2
8079368 Springmeyer Dec 2011 B2
8177805 Alferness May 2012 B2
8177809 Mavani et al. May 2012 B2
8192478 Khairkhahan et al. Jun 2012 B2
8257381 Dillard et al. Sep 2012 B2
8357139 Deem et al. Jan 2013 B2
8414655 Alferness et al. Apr 2013 B2
8444690 Gonzalez et al. May 2013 B2
8603127 Alferness Dec 2013 B2
8667973 Springmeyer Mar 2014 B2
20010010017 Letac et al. Jul 2001 A1
20020002401 McGuckin, Jr. et al. Jan 2002 A1
20020072730 McGill et al. Jun 2002 A1
20020077564 Campbell et al. Jun 2002 A1
20020077593 Perkins et al. Jun 2002 A1
20020077696 Zadno-Azizi et al. Jun 2002 A1
20020095209 Zadno-Azizi et al. Jul 2002 A1
20020112729 DeVore et al. Aug 2002 A1
20020147462 Mair et al. Oct 2002 A1
20030018327 Truckai et al. Jan 2003 A1
20030050648 Alferness et al. Mar 2003 A1
20030051733 Kotmel et al. Mar 2003 A1
20030055331 Kotmel et al. Mar 2003 A1
20030083730 Stinson May 2003 A1
20030121521 Hipolito et al. Jul 2003 A1
20030125763 McInnes Jul 2003 A1
20030127090 Gifford et al. Jul 2003 A1
20030154988 DeVore Aug 2003 A1
20030181890 Schulze et al. Sep 2003 A1
20030181922 Alferness Sep 2003 A1
20030183235 Rimbaugh et al. Oct 2003 A1
20030195385 De Vore Oct 2003 A1
20030199972 Zadno-Azizi et al. Oct 2003 A1
20030212412 Dillard et al. Nov 2003 A1
20030216769 Dillard et al. Nov 2003 A1
20030225445 Derus et al. Dec 2003 A1
20040010209 Sirokman Jan 2004 A1
20040024356 Tanaka Feb 2004 A1
20040039250 Tholfsen et al. Feb 2004 A1
20040040555 Tanaka Mar 2004 A1
20040059263 DeVore Mar 2004 A1
20040194780 Doshi Oct 2004 A1
20040206349 Alferness Oct 2004 A1
20040210248 Gordon et al. Oct 2004 A1
20040211412 Alferness et al. Oct 2004 A1
20040211434 Loomas et al. Oct 2004 A1
20040243140 Alferness et al. Dec 2004 A1
20050033310 Alferness et al. Feb 2005 A1
20050080434 Chung et al. Apr 2005 A1
20050096721 Mangin et al. May 2005 A1
20050137611 Escudero et al. Jun 2005 A1
20050145253 Wilson et al. Jul 2005 A1
20050222580 Gifford, III et al. Oct 2005 A1
20050245894 Zadno-Azizi Nov 2005 A1
20050267323 Dorros et al. Dec 2005 A1
20060032497 Doshi Feb 2006 A1
20060064123 Bonnette et al. Mar 2006 A1
20060100687 Fahey et al. May 2006 A1
20060200076 Gonzalez et al. Sep 2006 A1
20060206147 DeVore et al. Sep 2006 A1
20060235432 DeVore Oct 2006 A1
20060235467 DeVore Oct 2006 A1
20060241745 Solem et al. Oct 2006 A1
20060249164 Springmeyer Nov 2006 A1
20060270940 Tsukashima et al. Nov 2006 A1
20070209204 Chase et al. Sep 2007 A1
20070221230 Thompson et al. Sep 2007 A1
20070225747 Perkins et al. Sep 2007 A1
20080015627 DeVore Jan 2008 A1
20080132989 Snow et al. Jun 2008 A1
20080149446 Schuman Aug 2008 A1
20090188508 Smith, Jr. Jul 2009 A1
20090292262 Adams et al. Nov 2009 A1
20100082089 Quadri et al. Apr 2010 A1
20100262071 Kutsko et al. Oct 2010 A1
20110196295 Gonzalez Aug 2011 A1
20110201956 Alferness Aug 2011 A1
20120165856 Alferness Jun 2012 A1
20120289989 Dillard et al. Nov 2012 A1
20130190679 Springmeyer Jul 2013 A1
20130345737 Alferness Dec 2013 A1
20140031849 Gonzalez Jan 2014 A1
Foreign Referenced Citations (141)
Number Date Country
2002239759 May 2002 AU
2308186 May 1999 CA
2375752 Jan 2001 CA
2401331 Mar 2001 CA
2408923 Nov 2001 CA
2603948 Apr 2005 CA
2920188 Jul 2007 CN
101868199 Oct 2010 CN
102058443 May 2011 CN
100 04 979 Aug 2000 DE
0 665 029 Aug 1995 EP
0 743 071 Nov 1996 EP
1 078 601 Feb 2001 EP
1 151 729 Nov 2001 EP
1 157 663 Nov 2001 EP
1 206 276 May 2002 EP
1 198 269 Oct 2009 EP
1 494 632 Dec 2010 EP
03 716 212 Dec 2010 EP
2 353 557 Aug 2011 EP
2 520 321 Nov 2012 EP
1 496 790 Jun 2013 EP
2 773 702 Jul 1999 FR
2 082 071 Mar 1982 GB
2 324 729 Nov 1998 GB
2 348 138 Sep 2000 GB
1153639 Apr 2012 HK
58-163332 Sep 1983 JP
H02-104050 Aug 1990 JP
60-10740 Jan 1994 JP
H08-19544 Jan 1996 JP
2003-503162 Jan 2003 JP
2004-535887 Dec 2004 JP
2005-527297 Sep 2005 JP
3742010 Nov 2005 JP
2008-194250 Aug 2008 JP
4387803 Oct 2009 JP
2011-500171 Jan 2011 JP
2011-523363 Aug 2011 JP
2140211 Oct 1999 RU
852321 Aug 1981 SU
1371700 Feb 1988 SU
1593651 Sep 1990 SU
WO 8809683 Dec 1988 WO
WO 9003152 Apr 1990 WO
WO 9210725 Jun 1992 WO
WO 9426175 Nov 1994 WO
WO 9532018 Nov 1995 WO
WO 9604875 Feb 1996 WO
WO 9634582 Nov 1996 WO
WO 9637167 Nov 1996 WO
WO 9709932 Mar 1997 WO
WO 9713471 Apr 1997 WO
WO 9727893 Aug 1997 WO
WO 9742871 Nov 1997 WO
WO 9744085 Nov 1997 WO
WO 9800840 Jan 1998 WO
WO 9801084 Jan 1998 WO
WO 9808441 Mar 1998 WO
WO 9819633 May 1998 WO
WO 9839047 Sep 1998 WO
WO 9844854 Oct 1998 WO
WO 9848706 Nov 1998 WO
WO 9901076 Jan 1999 WO
WO 9913801 Mar 1999 WO
WO 9926692 Jun 1999 WO
WO 9932040 Jul 1999 WO
WO 9942059 Aug 1999 WO
WO 9942161 Aug 1999 WO
WO 9959503 Nov 1999 WO
WO 9964109 Dec 1999 WO
WO 0012011 Mar 2000 WO
WO 0018329 Apr 2000 WO
WO 0027292 May 2000 WO
WO 0042950 Jul 2000 WO
WO 0051500 Sep 2000 WO
WO 0051510 Sep 2000 WO
WO 0062699 Oct 2000 WO
WO 0078386 Dec 2000 WO
WO 0078407 Dec 2000 WO
WO 0102042 Jan 2001 WO
WO 0103641 Jan 2001 WO
WO 0103642 Jan 2001 WO
WO 0105334 Jan 2001 WO
WO 0110313 Feb 2001 WO
WO 0110314 Feb 2001 WO
WO 0112104 Feb 2001 WO
WO 0113839 Mar 2001 WO
WO 0113908 Mar 2001 WO
WO 0115604 Mar 2001 WO
WO 0128433 Apr 2001 WO
WO 0130266 May 2001 WO
WO 0130268 May 2001 WO
WO 0137897 May 2001 WO
WO 0145590 Jun 2001 WO
WO 0149213 Jul 2001 WO
WO 0152775 Jul 2001 WO
WO 0154585 Aug 2001 WO
WO 0154625 Aug 2001 WO
WO 0154685 Aug 2001 WO
WO 0166190 Sep 2001 WO
WO 0170114 Sep 2001 WO
WO 0174271 Oct 2001 WO
WO 0187170 Nov 2001 WO
WO 0189366 Nov 2001 WO
WO 0195786 Dec 2001 WO
WO 0205884 Jan 2002 WO
WO 0222053 Mar 2002 WO
WO 0222072 Mar 2002 WO
WO 0232333 Apr 2002 WO
WO 0234322 May 2002 WO
WO 0238038 May 2002 WO
WO 0247575 Jun 2002 WO
WO 02056794 Jul 2002 WO
WO 02064045 Aug 2002 WO
WO 02064190 Aug 2002 WO
WO 02069808 Sep 2002 WO
WO 02069823 Sep 2002 WO
WO 02087447 Nov 2002 WO
WO 02094087 Nov 2002 WO
WO 03022124 Mar 2003 WO
WO 03030975 Apr 2003 WO
WO 03003946 May 2003 WO
WO 03034927 May 2003 WO
WO 03041779 May 2003 WO
WO 03047468 Jun 2003 WO
WO 03078579 Sep 2003 WO
WO 03079944 Oct 2003 WO
WO 03088820 Oct 2003 WO
WO 03094996 Nov 2003 WO
WO 03099164 Dec 2003 WO
WO 2004010845 May 2004 WO
WO 2004080347 Sep 2004 WO
WO 2005013835 Feb 2005 WO
WO 2006034166 Mar 2006 WO
WO 2006124822 Nov 2006 WO
WO 2007123690 Nov 2007 WO
WO 2009049261 Apr 2009 WO
WO 2009135070 Nov 2009 WO
WO 2010118056 Oct 2010 WO
WO 2012158152 Nov 2012 WO
Non-Patent Literature Citations (153)
Entry
U.S. Appl. No. 12/721,426, filed Mar. 10, 2010, Pub. No. 2010/0256714, published Oct. 7, 2010, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 12/968,771, filed Dec. 15, 2010, Pub. No. 2011/0079221, published Apr. 7, 2011, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 13/005,444, filed Jan. 12, 2011, Pub. No. 2011/0208228, published Aug. 25, 2011, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 13/415,626, filed Dec. 10, 2013, Pub. No. 20120165856 published Jun. 28, 2012, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 13/286,995, filed Nov. 1, 2011, Pub. No. 2012/0101428 published Apr. 26, 2012, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 13/554,987, filed Jul. 20, 2012, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 13/706,061, filed Dec. 5, 2012, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 13/787,052, filed Mar. 6, 2013, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 13/853,433, filed Mar. 29, 2013, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
European Extended Search Report dated Sep. 9, 2013 for EP Application No. 12164169.0.
European Office Action of Jan. 8, 2009, Application No. 03716212.0.
US Office Action of Dec. 10, 2010, U.S. Appl. No. 11/880,090, filed Jul. 19, 2007.
U.S. Appl. No. 09/686,204, filed Oct. 10, 2000, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 09/379,972, filed Aug. 24, 1999, Pub. No. 2010/0256714, published Oct. 7, 2010 and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 09/780,232, filed Feb. 9, 2001, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 09/912,613, filed Jul. 24, 2001, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/052,875, filed Oct. 25, 2001, Pub. No. 2003/0083671, published May 1, 2003, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 09/881,862, filed Jun. 14, 2011, Pub. No. 2001/0052344, published Dec. 20, 2001 and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/081,712, filed Mar. 6, 2002, Pub. No. 2002/0112729, published Aug. 22, 2002, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/317,667, filed Dec. 11, 2002, Pub. No. 2003/0158515, published Aug. 21, 2003, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/409,785, filed Apr. 8, 2003, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/259,007, filed Sep. 26, 2002, Pub. No. 2003/0212337, published Nov. 13, 2003, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/784,906, filed Feb. 23, 2004, Pub. No. 2004/0220496, published Nov. 4, 2004, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/744,577, filed Dec. 22, 2003, Pub. No. 2004/0167636, published Aug. 26, 2004, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/260,012, filed Oct. 26, 2005, Pub. No. 2006/0155217, published Jul. 13, 2006, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/745,401, filed Dec. 22, 2003, Pub. No. 2005/0137714, published Jun. 23, 2005, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/585,415, filed Oct. 24, 2006, Pub. No. 2007/0232992, published Oct. 4, 2007, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 12/428,287, filed Apr. 22, 2009, Pub. No. 2009/0205667, published Aug. 20, 2009, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/738,412, filed Apr. 20, 2007, Pub. No. 2007/0250022, published Oct. 25, 2007, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/746,981, filed Dec. 23, 2003, Pub. No. 2004/0143282, published Jul. 22, 2004, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/933,778, filed Sep. 3, 2004, Pub. No. 2005/0033344, published Feb. 10, 2005, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 12/398,122, filed Mar. 4, 2009, Pub. No. 2009/0182369, published Jul. 16, 2009, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/733,710, filed Apr. 10, 2007, Pub. No. 2007/0185531, published Aug. 9, 2007, and is ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/204,383, filed May 3, 2006, Pub. No. 2006/0200076, published Sep. 7, 2006, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/880,090, Pub. No. 2008/0119866, published May 22, 2008, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 13/198,546, filed Aug. 4, 2011, Pub. No. 2011/0283998, published Nov. 24, 2011, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 12/828,629, filed Jul. 1, 2010, Pub. No. 2011/0054632, published Mar. 3, 2011, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/150,547, filed May 17, 2002, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/178,073, filed Jun. 21, 2001, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/081,712, filed Feb. 21, 2002, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 09/951,105, filed Sep. 11, 2001, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/178,073, filed Jun. 21, 2002, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/103,487, filed Mar. 20, 2002, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/418,929, filed Apr. 17, 2003, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/124,790, filed Apr. 16, 2002, and its ongoing prosecution history including without limitaiton Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/143,353, filed May 9, 2002, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/196,513, filed Jul. 15, 2002, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/254,392, filed Sep. 24, 2002, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/827,384, filed Apr. 19, 2004, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/847,554, filed May 17, 2004, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/387,963, filed Mar. 12, 2003, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/847,427, filed May 17, 2004, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Patent Application Serial No. 10/48,041, filed May 18, 2004, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 10/848,571, filed Feb. 10, 2005, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/178,640, filed Jul. 11, 2005, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/417,738, May 3, 2006, Issued as 7,042,931 on May 17, 2011, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/418,541, filed May 3, 2006, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/417,553, filed May 3, 2006, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/416,337, filed May 2, 2006, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/417,944, filed May 3, 2006, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 11/781,130, filed Jul. 20, 2007, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 13/073,443, filed Mar. 28, 2011, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 12/913,257, filed Oct. 27, 2010, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
U.S. Appl. No. 13/415,616, filed Mar. 8, 2012, and its ongoing prosecution history including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents.
Amendment mailed Mar. 3, 2004 in response to Office Action dated Oct. 3, 2003 in the related copending U.S. Appl. No. 09/951,105.
Andre A. Kulisz, Autocath 100—Nonsurgical, Intraurethral Bladder Control Device for Urinary Incontinent and Urinary Retentive Women—Another Dr. Kulisz's Development, http://www.kulisz.com/autocath.htm, 2003, 3 pp.
April et al. “Correction of Funnel-Chest According to Senning-Johnson”, Schweiz. Rundchau. Med. (PRAXIS) 79, Nr. 12 (1980) pp. 356-360.
Chest Drains, from webmaster@atroi.ed/cp., from website Mar. 21, 2002; pp. 1-3.
Chest Drains, from webmaster@surgical-tutor.org.uk; from Website on Mar. 21, 2002; pp. 1-3.
Dillard et al.,“Evaluation of a Novel Intra-bronchial Valve Device to Produce Lung Volume Reduction,” Poster show at conference in Jun. 2002.
EDO Ceramics Products and Services, from webmaster@edocorp.com; from website on Mar. 21, 2002; pp. 1,2.
Ellis, James H., Balloon Catheter Occlusion of Bronchopleural Fistulae, May 7, 1981, AJR: 138, Jan. 1982, p. 157-159.
EWS Endobronchial Watanabe Spigots, Novatech, edited Apr. 17, 2002.
Exploring Chest Drain Options; from webmaster google.com; RNWeb: Continuing Education; from website on Mar. 21, 2002; pp. 1-6.
Harris et al., “The Experimental Production in Dogs of Emphysema with Associated Asthmatic Syndrome by Means of an Intratracheal Ball Valve,” J Exp Med 30:1919; 75-88.
Horiuchi et al: Three Cases of Intractable Pneumothorax Treated Successfully by Bronchial Embolization using Silicon; JJSB, 2001. pp. 25-30.
Inaspettato: Endoscopic Treatment of Bronchopleural Fistulas Using N-butyl-2-cyanoacrylate; Surgical Laparoscopy & Endoscopy; vol. 4 No. 1, pp. 62-64, 1994.
J&J Gateway LLC Web Page: Steps in the MAMMOTOME Surgical Procedure; Surgical Technique, Dec. 28, 2001; p. 1-3.
Jones et al: Closure of a Benign Broncho-Oesophageal Fistula by Endoscopic Injection of Bovine Collagen, Cyanoacrylate Glue and Gelfoam; 1996, pp. 53-55 Aust. N.Z. J.. Surg.
Lewis et al, “Pulmonary Interstitial Emphysema: Selective Bronchial Occlusion with a Swan-Ganz Catheter.” Archives of Disease in Childhood, 63:1988, 313-315.
Marco: Bubble Detector, from webmaster@marco.de, from Website on Mar. 21, 2002; pp. 1-3.
Matthew et al. “Selective Bronchial Obstruction for Treatment of Bullous Interstitial Emphysema,” J. of Ped. 96:1980, 475-477.
Oasis Dry Suction Chest Drains; Instructions for Use; Atrium Medical Corporation, Hudson New Hampshire, on Mar. 27, 2002,pp. 1-4.
Okada et al: Emergent Bronchofiberoptic Bronchial Occlusion for Intractable Pneumothorax with Severe Emphysema; The Japanese Journal of Thoracic and Cardiovascular Surgery, 1998. pp. 1078-1081, vol. 48 No. 11.
Ochsner et al. “Chone-Chondrosternon”, Journal of Thoracic Surgery, vol. 8, No. 5, Jun. 1939, pp. 469-511.
Puhakka et al., “Acute Bronchial Obstruction: An Experimental Rabbit Model Study.” Int. J. of Pediatric Otorhinolaryngology. 18:1989, 107-118.
Shamberger, “Congenital Chest Wall Deformities” Current Problems in Surgery vol. XXXIII, No. 6, Jun. 1996, pp. 470-543.
SIII Control and Display Modules; from webmaster@stoeckert.de; from website on Mar. 21, 2002, pp. 15.
Snider et al., “The Definition of Emphysema: Report of the National Heart Lung and Blood Institute, Division of Lung Diseases Workshop”, Am. Ev. Respir. Dis., 132:182-185, 1985.
Tanase, D., et al.: “Investigation of Multi-Sensor Techniques for Cardiac-Output Measurements in Intensive Care,” Microtechnology in Medicine and Biology, 2005, 3rd IEEE/EMB, Special Topic Conference, pp. 122-125.
Tube Thoracostomy; from webmaster@merck.com/pubs/manual; from Website Mar. 21, 2003, pp. 1,2.
Understanding Chest Drainage; from webmaster@nursingceu.com; from website on Mar. 21, 2002; pp. 1-15.
Watanabe et al: Bronchial Embolization Using Dental Impression Material in a Case of Pyelo-bronchial Fistula with Candida Fungemia; 1991. Journal of the Japan Society for Bronchology, pp. 607-610.
European Supplemental Search Report in European Appln. No. 00969008.2, dated Feb. 26, 2004, 5 pp.
International Search Report in International application No. PCT/US00/40701, mailed Jan. 25, 2001, 3 pp.
Canadian Office Action dated Apr. 28, 2009 for Canadian Application No. 2,459,702.
Canadian Office Action dated Dec. 14, 2010 for Canadian Application No. 2,459,702.
Canadian Office Action dated Mar. 9, 2010 for Canadian Application No. 2,459,702.
European Search Report in European Appln. No. 02759335.9, dated Jan. 31, 2007.
International Search Report in International application No. PCT/US02/25555, mailed Mar. 19, 2003, 4 pp.
Extended European Search Report for EP 08 0205468, dated Jul. 28, 2009.
European Examination Report dated Apr. 17, 2012 for EP Application No. 08 022 468.6.
European Examination Report dated Apr. 14, 2010 for EP Application No. 03 71 0804.
European Supplemental Search Report dated Nov. 9, 2009 for EP Application No. 03 71 0804.
European Examination Report dated Dec. 30, 2011 for EP Application No. 03 71 0804.
European Extended Search Reporded dated Oct. 8, 2012 for EP Application No. 12164169.0.
European Examination Report of Apr. 28, 2011, Application No. 10196887.3-1269.
European Extended Search Report dated Mar. 5, 2013, Application No. 10196887.3-1269.
Australian Office Action of Oct. 29, 2007, Application No. 2003219927.
European Notice re Amendment of Application Documents of Jun. 17, 2009, Application No. 03 716 212.0-1265.
European Supplemental Search Report of Feb. 28, 2008, Application No. 03 716 212.0-1265.
European Office Action of Dec. 23, 2008, Application No. 03 716 212.0-1265.
European Office Action of Mar. 8, 2013, Application No. 03716212.0.
Japanese Office Action re JP Application No. JP 2009-503031, mailed Mar. 6, 2012, and English translation in 9 pages.
Notice of Reasons for Rejection re JP Application No. JP 2009-503031, mailed on Jul. 10, 2012 in six pages.
Japanese Office Action of Feb. 3, 2009, Application No. 2003-577779.
International Search Report of Jul. 7, 2003, Application No. PCT/US03/05968.
Canadian Office Action dated Nov. 5, 2009, re Application No. 2,484,086 in 2 pages.
International Search Report dated Oct. 1, 2003 re PCT Application No. PCT/US2003/14868.
PCT International Preliminary Report on Patentability from corresponding PCT Application No. PCT/US2004/007721, mailed Nov. 25, 2005.
PCT Search Report and Written Opinion from corresponding PCT Application No. PCT/US2004/007721, dated May 4, 2005.
Chinese Office Action dated Jun. 4, 2010 re CN Application No. 200780019455.6.
Chinese Office Action dated Sep. 28, 2012 (with translation) re CN Application No. 201110022562.2.
Japanese Office Action dated Mar. 6, 2012, JP Application No. 2009-503031 w/translation.
Japanese Office Action dated Jul. 2, 2012, JP Application No. 2009-503031 w/translation.
PCT International Search Report from corresponding PCT Application No. PCT/US2007/007923, dated May 20, 2008 in 2 pages, re.
PCT Preliminary and Written Report from corresponding PCT Application No. PCT/US2007/007923, dated Sep. 30, 2008 in 7 pages, re.
Russian Office Action, for App. No. 2008139081/14(050381), dated Nov. 24, 2010.
International Preliminary Report on Patentability for Application No. PCT/US2010/030131, dated Mar. 18, 2011.
International Report on Patentability dated Dec. 23, 2009 re PCT/US2008/079650.
International Search Report and Written Opinion for Application No. PCT/US2010/030131, dated Jun. 18, 2010.
International Search Report dated Jan. 30, 2009 re PCT/US2008/079650.
Chinese Office Action dated Mar. 20, 2012 re CN App. No. 200880117320.8.
English Translation of Chinese First Office Action mailed Mar. 20, 2012 for Chinese Patent Application No. 200880117320.8.
Chinese Second Office Action issued Oct. 8, 2012 for Chinese Patent Application No. 200880117320.8.
Chinese Third Office Action issued Mar. 5, 2013 for Chinese Patent Application No. 200880117320.8.
European Examination Report, re EP Application No. 08 837 761.9, dated Jan. 3, 2013.
Japanese Notice of Reasons for Rejection, re JP Application No. 2010-529122, dated Jan. 22, 2013.
International Search Report and Written Opinion for Application No. PCT/US2004/025458, mailed Nov. 30, 2004.
Chinese Office Action, re CN Application No. 2012082800791790, dated Aug. 31, 2012.
European Office Action of Dec. 8, 2010, Application No. 09739872.1.
European Office Action on May 6, 2011, Application No. 09739872.1.
European Examination Report dated Oct. 12, 2011 for EP Application No. 09 739 872.1.
International Search Report and Written Opinion re PCT App. No. PCT/US2011/36549, mailed Sep. 16, 2011.
US Office Action mailed Oct. 3, 2003 from related copending U.S. Appl. No. 09/951,105.
Amendment mailed Mar. 3, 2004 in response to Office Action dated Oct. 3, 2003 in the related co-pending U.S. Appl. No. 09/951,105.
US Office Action of Feb. 8, 2006, U.S. Appl. No. 10/103,487, filed Mar. 3, 2002.
US Office Action of Jun. 14, 2005, U.S. Appl. No. 10/103,487, filed Mar. 3, 2002.
US Office Action of Mar. 22, 2007, U.S. Appl. No. 10/103,487, filed Mar. 3, 2002.
US Office Action of May 19, 2006, U.S. Appl. No. 10/103,487, filed Mar. 3, 2002.
US Office Action of Oct. 20, 2004, U.S. Appl. No. 10/103,487, filed Mar. 3, 2002.
US Office Action of Sep. 12, 2006, U.S. Appl. No. 10/103,487, filed Mar. 3, 2002.
US Office Action/Notice of Allowance dated Jul. 1, 2011, U.S. Appl. No. 11/880,090, filed Jul. 19, 2007.
Related Publications (1)
Number Date Country
20140128903 A1 May 2014 US
Continuations (4)
Number Date Country
Parent 13415616 Mar 2012 US
Child 13853345 US
Parent 13198546 Aug 2011 US
Child 13415616 US
Parent 11880090 Jul 2007 US
Child 13198546 US
Parent 10103487 Mar 2002 US
Child 11880090 US